menu search

Here are 3 marijuana stocks for cannabis investors to watch right now

The cannabis industry over the last several years continues to grow and progress. Between more states g...

November 4, 2023, 10:19 am

A good buy rating: travelzoo looks poised for upside

Travelzoo is an internet media company that generates revenue through travel advertising and exclusive deals curated by global experts. The introducti...

November 4, 2023, 7:09 am

Jubilee metals ceo talks progress and prospects - icymi

In conversation with Thomas Warner from Proactive, Leon Coetzer, CEO of Jubilee Metals Group PLC (AIM:JLP, JSE:JBL, OTC:JUBPF), delved into the strat...

November 4, 2023, 6:38 am

Chewy: pharmacy remains a big opportunity, but stock looks fairly valued

Chewy's autoship program is a major strength, with 75.5% of sales coming from autoship customers. The c...

November 4, 2023, 6:19 am

Kefi gold and copper: a comprehensive update on operational progress and market dynamics - icymi

In this interview, Thomas Warner from Proactive chats with Harry Anagnostaras-Adams, the executive chairman of KEFI Gold and Copper PLC (AIM:KEFI, OT...

November 4, 2023, 5:29 am

Xrp news: sec v ripple recap as the november 9 countdown begins

Amid the SEC v Ripple lawsuit, Bill Hinman’s role and the programmatic Sales ruling could take center...

November 4, 2023, 12:58 am

Correction: national youth prevention summit highlights colorado campaign to protect teens from fentanyl

This release has been corrected to identify the source as SE2 Denver, Colo., Nov. 03, 2023 (GLOBE NEWSWIRE) — A national youth prevention summit org...

November 3, 2023, 11:10 pm

Prime medicine reports third quarter 2023 financial results and provides business updates

— Presented new preclinical research across multiple programs, including proof-of-concept data from i...

November 3, 2023, 8:01 pm

Update: korro bio and frequency therapeutics announce closing of merger and private placement of $117 million

Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction ca...

November 3, 2023, 7:31 pm

Actinium pharmaceuticals: the trickle down continues, and i maintain a buy

Actinium Pharmaceuticals continues to make progress with their radiolabelled CD45 antibody Iomab-B, whi...

November 3, 2023, 6:08 pm

Cal-soap’s 20th anniversary with live oak injury law group

GILROY, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Attorney Richard E. Eichenbaum, Esq., founder of Live Oak Injury Law Group was pleased to attend as...

November 3, 2023, 6:00 pm

Korro bio and frequency therapeutics announce closing of merger and private placement of $117 million

Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction ca...

November 3, 2023, 4:19 pm

4%-yielding southern company is a utility gem

Southern Company's stock has performed well, up over 90% in the past five years, and its recent earnings report showed positive ...

November 3, 2023, 4:17 pm

Podcastone (podc) expands slate of original programming, acquires exclusive rights to vigilante podcast, including ip for tv/ film

Vigilante Named “Best True Crime Podcast” in Its Debut, Over 2 Million Downloads to Date Year to Date PodcastOne Has Added 18 New ...

November 3, 2023, 3:50 pm

Oceana: coca-cola and pepsi’s plastic packaging use increases by hundreds of millions of pounds

Oceana calls on both companies to increase reusable packaging and reduce single-use plastic, after Ellen MacArthur Foundation report reveals significa...

November 3, 2023, 2:06 pm

Coherus presents data from next-generation immuno-oncology programs at 38th annual meeting of society for immunotherapy of cancer (sitc)

– Data demonstrate distinct IL-27-mediated expression of genes associated with immune suppression in vitro, supporting ongoing clinical development ...

November 3, 2023, 12:30 pm

Why redfin stock catapulted higher today

Redfin is making progress toward revenue growth again. The company reported positive adjusted EBITDA in...

November 3, 2023, 12:24 pm

Protara therapeutics announces third quarter 2023 financial results and business update

Dosing is progressing well in ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preli...

November 3, 2023, 12:00 pm

Galectin therapeutics to share five scientific presentations at the liver meeting™ 2023, hosted by the aasld

Pharmacokinetics and safety of belapectin in patients with hepatic insufficiency Lack of impact of belapectin on cardiac repolarization (QT interval) ...

November 3, 2023, 12:00 pm


Search within

Pages Search Results: